These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 31374171)
1. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy. Shan L; Fan W; Wang W; Tang W; Yang Z; Wang Z; Liu Y; Shen Z; Dai Y; Cheng S; Jacobson O; Zhai K; Hu J; Ma Y; Kiesewetter DO; Gao G; Chen X ACS Nano; 2019 Aug; 13(8):8903-8916. PubMed ID: 31374171 [TBL] [Abstract][Full Text] [Related]
2. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789 [TBL] [Abstract][Full Text] [Related]
3. Self-accelerating H Tang Y; Ji Y; Yi C; Cheng D; Wang B; Fu Y; Xu Y; Qian X; Choonara YE; Pillay V; Zhu W; Liu Y; Nie Z Theranostics; 2020; 10(19):8691-8704. PubMed ID: 32754272 [No Abstract] [Full Text] [Related]
4. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy. Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804 [TBL] [Abstract][Full Text] [Related]
5. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression. Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800 [No Abstract] [Full Text] [Related]
6. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors. Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331 [TBL] [Abstract][Full Text] [Related]
8. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies. Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277 [TBL] [Abstract][Full Text] [Related]
9. Nanoclustered Cascaded Enzymes for Targeted Tumor Starvation and Deoxygenation-Activated Chemotherapy without Systemic Toxicity. Ma Y; Zhao Y; Bejjanki NK; Tang X; Jiang W; Dou J; Khan MI; Wang Q; Xia J; Liu H; You YZ; Zhang G; Wang Y; Wang J ACS Nano; 2019 Aug; 13(8):8890-8902. PubMed ID: 31291092 [TBL] [Abstract][Full Text] [Related]
10. A multifunctional oxygen-producing MnO Yang C; Liu Y; Su S; Gao N; Jing J; Zhang X J Mater Chem B; 2020 Nov; 8(43):9943-9950. PubMed ID: 33034314 [TBL] [Abstract][Full Text] [Related]
11. Janus Gold Triangle-Mesoporous Silica Nanoplatforms for Hypoxia-Activated Radio-Chemo-Photothermal Therapy of Liver Cancer. Wang Z; Chang ZM; Shao D; Zhang F; Chen F; Li L; Ge MF; Hu R; Zheng X; Wang Y; Dong WF ACS Appl Mater Interfaces; 2019 Sep; 11(38):34755-34765. PubMed ID: 31474108 [TBL] [Abstract][Full Text] [Related]
12. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy. Yu H; Li Y; Zhang Z; Ren J; Zhang L; Xu Z; Kang Y; Xue P Acta Biomater; 2022 Jan; 138():545-560. PubMed ID: 34775125 [TBL] [Abstract][Full Text] [Related]
13. H Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965 [TBL] [Abstract][Full Text] [Related]
14. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223 [TBL] [Abstract][Full Text] [Related]
15. Enhanced Cancer Starvation Therapy Based on Glucose Oxidase/3-Methyladenine-Loaded Dendritic Mesoporous OrganoSilicon Nanoparticles. Wu F; Liu Y; Cheng H; Meng Y; Shi J; Chen Y; Wu Y Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572575 [TBL] [Abstract][Full Text] [Related]
16. Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy. Tang W; Fan W; Wang Z; Zhang W; Zhou S; Liu Y; Yang Z; Shao E; Zhang G; Jacobson O; Shan L; Tian R; Cheng S; Lin L; Dai Y; Shen Z; Niu G; Xie J; Chen X ACS Nano; 2018 Dec; 12(12):12269-12283. PubMed ID: 30418749 [TBL] [Abstract][Full Text] [Related]
17. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy. Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996 [TBL] [Abstract][Full Text] [Related]
18. Albumin-MnO Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612 [TBL] [Abstract][Full Text] [Related]
19. Tumor Starvation Induced Spatiotemporal Control over Chemotherapy for Synergistic Therapy. Zhang MK; Li CX; Wang SB; Liu T; Song XL; Yang XQ; Feng J; Zhang XZ Small; 2018 Dec; 14(50):e1803602. PubMed ID: 30370690 [TBL] [Abstract][Full Text] [Related]
20. Mesoporous Silica-Coated Silver Nanoframes as Drug-Delivery Vehicles for Chemo/Starvation/Metal Ion Multimodality Therapy. Zhang Y; Li Y; Gao Z; Ding B; An P; Zhang X; Sun B; Sun B Langmuir; 2020 Jun; 36(23):6345-6351. PubMed ID: 32388995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]